Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard
Sparta Pharmaceutical Corporation, Horsham, PA, United States
Search 7 grants from Howard Sands
Search grants from Sparta Pharmaceutical Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Cellular mechanisms by which exhausted T cell responses are restored
Reducing Sedative Exposure in Ventilated ICU Patients
Virtual Simulation of Temporal Bone Dissection
Sustained HIV1 Suppression Despite Drug Resistance
Microbially-Active Functional Material Based Bioreactors for Continuous Production of Biofuels and Industrial Feedstock
Recently added grants:
Project 03: Leukemia Research (LR)
Project 04: Molecular Carcinogenesis and Chemoprevention (MCC)
Project 05: Translational Therapeutics (TT)
Community Outreach and Engagement
Developmental Funds
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44NS036100-02A1
Application #
2431317
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (11))
Program Officer
Jacobs, Tom P
Project Start
1995-08-15
Project End
1999-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Sparta Pharmaceutical Corporation
Department
Type
DUNS #
City
Horsham
State
PA
Country
United States
Zip Code
19044
Related projects
NIH 1998
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
NIH 1997
R44 NS
Novel Recombinant Serpin for the Treatment of Stroke
Sands, Howard / Sparta Pharmaceutical Corporation
Comments
Be the first to comment on Howard Sands's grant